PHAR
Pharming Group N.V. ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$14.51
-0.63 ▼ -4.16%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$14.51
+0.00 +0.00%
| Index | - | P/E | 478.88 | EPS (ttm) | 0.03 | Insider Own | - | Shs Outstand | 0.07B | Perf Week | -6.02% |
| Market Cap | 1.02B | Forward P/E | 71.21 | EPS next Y | 20.92% | Insider Trans | - | Shs Float | - | Perf Month | -6.81% |
| Enterprise Value | 0.95B | PEG | 1.09 | EPS next Q | 0.01 | Inst Own | 1.41% | Short Float | - | Perf Quarter | -16.99% |
| Income | 0.00B | P/S | 2.7 | EPS this Y | 321.25% | Inst Trans | 74.8% | Short Ratio | 0.39 | Perf Half Y | -1.96% |
| Sales | 0.38B | P/B | 3.76 | EPS next 5Y | 65.1% | ROA | 0.59% | Short Interest | 0.01M | Perf YTD | -17.88% |
| Book/sh | 3.86 | P/C | 5.66 | EPS past 3/5Y | -42.5% -41.63% | ROE | 1.08% | 52W High | -32.01% ($21.34) | Perf Year | 66.02% |
| Cash/sh | 2.56 | P/FCF | 20.63 | Sales past 3/5Y | 22.4% 12.25% | ROIC | 0.7% | 52W Low | 93.42% ($7.50) | Perf 3Y | 19.82% |
| Dividend Est. | - | EV/EBITDA | 23.44 | EPS Y/Y TTM | 105.57% | Gross Margin | 90.03% | Volatility(W/M) | 5.46% 4.34% | Perf 5Y | 8.04% |
| Dividend TTM | - | EV/Sales | 2.53 | Sales Y/Y TTM | 27.05% | Oper. Margin | 7.81% | ATR (14) | 0.85 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.03 | EPS Q/Q | 29.44% | Profit Margin | 0.71% | RSI (14) | 36.75 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.59 | Sales Q/Q | 15.62% | SMA20 | -9.72% ($16.07) | Beta | 0.08 | Target Price | $30.08 |
| Payout | - | Debt/Eq | 0.42 | Earnings | 3000000 | SMA50 | -15.77% ($17.23) | Rel Volume | 1.24 | Prev Close | $15.14 |
| Employees | - | LT Debt/Eq | 0.39 | EPS/Sales Surpr. | 366.67% -4.71% | SMA200 | 0.1% ($14.5) | Avg Volume(3M) | 0.03M | Price | $14.51 |
| IPO | 2020/12/23 | Option/Short | No/Yes | Trades | 299 | Volume | 35,942 | Change | -4.16% |
뉴스 로딩 중...